Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.29 – $9.00
100% from low
No one on the platform currently holds AXL.
No tracked institution reports a position in AXL as of their last filing.
No one on the platform has traded AXL yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $5.9B | +0.8% | $0.47 | $-0.04–$0.87 | 19.1× | 5 |
| 2027 | $6.1B | +3.0% | $0.77 | $0.47–$1.07 | 11.7× | 2 |
| 2028 | $6.0B | -1.8% | $0.63 | $0.62–$0.65 | 14.2× | 1 |
| 2029 | $6.4B | +6.7% | $1.25 | $1.23–$1.29 | 7.2× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-02-13 | $-0.07 | $-0.06 | +14.3% |
| 2025-11-07 | $0.12 | $0.16 | +33.3% |
| 2025-08-08 | $0.13 | $0.21 | +61.5% |
| 2025-05-02 | $0.02 | $0.09 | +350.0% |
| 2025-02-14 | $-0.06 | $-0.06 | +0.0% |
| 2024-11-08 | $0.03 | $0.20 | +508.1% |
| 2024-08-09 | $0.11 | $0.19 | +72.7% |
| 2024-05-03 | $0.02 |
| $0.18 |
| +778.0% |
| -0.58% |
| $1.3B |
| — |
| CPSCooper-Standard Holdings Inc. | $27.23 | -1.23% | $483M | — |
| ECXECARX Holdings, Inc. | $1.07 | +2.38% | $373M | — |
Source: Financial Modeling Prep · peers by sector/industry
$AXL Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.00 • Reported revenue of $2.96B up 92.40% YoY • Dauch Corporation updated its full year 2026 financial targets, projecting sales of $10.6 - $10.8 billion, Adjusted EBITDA of $1.36 - $1.425 billion, and Adjusted free cash flow of $260 - $325 million.
View on StockTwits ↗$AXL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.52 down -966.67% YoY • Reported revenue of $2.38B up 68.56% YoY • Dauch updated its full year 2026 financial targets, expecting sales between $10.3B and $10.8B, and Adjusted EBITDA from $1.3B to $1.43B, including $50M in synergy benefits.
View on StockTwits ↗$AXL $AXL Down 38% in just over a month now. Should've renamed it Douche instead of Dauch.
View on StockTwits ↗Wall St is expecting 0.04 EPS for $AXL Q1 [Reporting 05/01 BMO] http://www.estimize.com/intro/axl?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$AXL absolutely infuriating for shareholders -20%!!. I feel bad for shareholders. Glad i did my usual sell ahead of the ER. I'm adding shares today, to keep it on my screens. Will wait till chart bases out and revisit.
View on StockTwits ↗$AXL Are analysts just stupid or are they lying agents for the investment bankers bringing in the M&A fees? Merger hopes and dreams meets realilty of making it all work in one chart:
View on StockTwits ↗$AXL Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.63 down -425.00% YoY • Reported revenue of $1.38B up 0.22% YoY • Dauch targets full year 2026 sales between $10.3B and $10.7B, Adjusted EBITDA from $1.3B to $1.4B, and Adjusted free cash flow from $235M to $325M, including Dowlais's partial year contribution.
View on StockTwits ↗$AXL 1W CCI shows bottoming signs while 1D STOCH indicates a momentum shift. 4H RSI remains range-bound, yet 30M liquidity flows suggest a breakout is imminent if volume confirms the move. @DailyAnalysis
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.